Phio Pharmaceuticals Has Been Granted A Skin Care Patent In South Korea For Intasyl Compound That Targets Photo-Aging
Portfolio Pulse from Benzinga Newsdesk
Phio Pharmaceuticals has been granted a patent in South Korea for its Intasyl compound, which targets photo-aging in skin care.
June 18, 2024 | 11:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phio Pharmaceuticals has been granted a patent in South Korea for its Intasyl compound, which targets photo-aging in skin care. This development could enhance the company's market position and open new revenue streams.
The granting of a patent in South Korea for the Intasyl compound is a significant milestone for Phio Pharmaceuticals. It not only validates the technology but also opens up a new market, potentially leading to increased revenue and market share.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100